Aggressive Adult Non-Hodgkin Lymphoma — Trials

Aggressive Adult Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

193 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 11
Ph III recruiting: 0
Growth YoY: —
Industry share: 11%
Top sponsor: City of Hope Medical Center
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (44)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02481310	Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma	unknown	Phase 1 / Phase 2	38	Northwestern UniversityOTHER	1	Feb 21, 2022	clinicaltrials
NCT04008394	Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies	unknown	Phase 1	50	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER	1	Aug 7, 2019